PT1123396E - Promotores minimos e seus usos - Google Patents

Promotores minimos e seus usos

Info

Publication number
PT1123396E
PT1123396E PT99960139T PT99960139T PT1123396E PT 1123396 E PT1123396 E PT 1123396E PT 99960139 T PT99960139 T PT 99960139T PT 99960139 T PT99960139 T PT 99960139T PT 1123396 E PT1123396 E PT 1123396E
Authority
PT
Portugal
Prior art keywords
reagents
promoters
minimum
minimum promoters
methods
Prior art date
Application number
PT99960139T
Other languages
English (en)
Inventor
James T Fuller
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22302848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1123396(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of PT1123396E publication Critical patent/PT1123396E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
PT99960139T 1998-10-19 1999-10-19 Promotores minimos e seus usos PT1123396E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10487198P 1998-10-19 1998-10-19

Publications (1)

Publication Number Publication Date
PT1123396E true PT1123396E (pt) 2006-07-31

Family

ID=22302848

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99960139T PT1123396E (pt) 1998-10-19 1999-10-19 Promotores minimos e seus usos

Country Status (14)

Country Link
US (1) US20070009487A1 (pt)
EP (1) EP1123396B1 (pt)
JP (1) JP2002527527A (pt)
AT (1) ATE319826T1 (pt)
AU (1) AU766005B2 (pt)
CA (1) CA2347369A1 (pt)
CY (1) CY1105034T1 (pt)
DE (1) DE69930294T2 (pt)
DK (1) DK1123396T3 (pt)
ES (1) ES2259846T3 (pt)
IL (2) IL142680A0 (pt)
NZ (1) NZ511798A (pt)
PT (1) PT1123396E (pt)
WO (1) WO2000023592A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
BRPI0415204A (pt) 2003-10-10 2006-12-05 Powderject Vaccines Inc construção de ácido nucleico, métodos de obtenção da expressão em células de mamìferos de um polipeptìdeo de interesse, e de imunização com ácido nucleico, partìculas revestidas, receptáculo de dosagem para um dispositivo de liberação mediada por partìculas, dispositivo de liberação mediada por partìculas, e, sequência de promotor quimérico isolada purificada
US20240123086A1 (en) * 2021-02-24 2024-04-18 University Of Massachusetts Inducible single aav system and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4629782A (en) * 1984-12-21 1986-12-16 Syntex (U.S.A.) Inc. Crystalline form of N-acetylmuramyl-L-α-aminobutyryl-D-isoglutamine
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5120657A (en) * 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
GB8717430D0 (en) * 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
WO1991007487A1 (en) * 1989-11-16 1991-05-30 Duke University Particle-mediated transformation of animal tissue cells
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5558644A (en) * 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5888981A (en) * 1993-06-14 1999-03-30 Basf Aktiengesellschaft Methods for regulating gene expression
CN1112943C (zh) * 1994-01-21 2003-07-02 粉剂注射疫苗股份有限公司 气体驱动的基因送递装置
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
FR2735789B1 (fr) * 1995-06-23 1997-07-25 Centre Nat Rech Scient Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
GB9605690D0 (en) * 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
US5891718A (en) * 1996-03-27 1999-04-06 Vical Incorporated Tetracycline inducible/repressible systems
US6156567A (en) * 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
AU719629B2 (en) * 1996-11-08 2000-05-11 Oklahoma Medical Research Foundation Endothelium specific expression regulated by EPCR control elements
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression
US6368825B1 (en) * 1998-08-10 2002-04-09 Academia Sinica Baculovirus containing minimal CMV promoter

Also Published As

Publication number Publication date
AU766005B2 (en) 2003-10-09
EP1123396A2 (en) 2001-08-16
US20070009487A1 (en) 2007-01-11
EP1123396B1 (en) 2006-03-08
CA2347369A1 (en) 2000-04-27
DK1123396T3 (da) 2006-07-10
DE69930294D1 (de) 2006-05-04
WO2000023592A3 (en) 2000-07-27
WO2000023592B1 (en) 2000-09-08
WO2000023592A2 (en) 2000-04-27
WO2000023592A9 (en) 2000-09-28
DE69930294T2 (de) 2006-11-02
AU1707300A (en) 2000-05-08
ES2259846T3 (es) 2006-10-16
IL142680A (en) 2010-04-15
NZ511798A (en) 2004-01-30
CY1105034T1 (el) 2010-03-03
ATE319826T1 (de) 2006-03-15
IL142680A0 (en) 2002-03-10
JP2002527527A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
DK1870417T3 (da) Peptidacceptor-ligeringsmetoder
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
DK0910633T3 (da) Hybrid polyketidsyntase I-gen
LV11486A (lv) Fermenti DNS sekvenesanai
DE68924227T2 (de) DNA-Fragment.
DE69836267D1 (de) Nukleinsäuren aus der artischocke (cynara scolymus), welche für ein enzym mit fruktosylpolymerase-aktivität kodieren
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
DK0599868T3 (da) Polyphenoloxidase-gener
WO1995006764A3 (en) Oligonucleotides with rna cleavage activity
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
PT1123396E (pt) Promotores minimos e seus usos
FI902803A0 (fi) Dna-sekvens som kodar en a-amylas-pullulanasenzym.
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DK1032683T3 (da) Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
EA199801007A1 (ru) Способ биосинтеза, позволяющий получать кобаламины
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
DK43393D0 (da) Dna-sekvens, der koder for et enzym
DK199900148A (da) Enzym samt DNA-sekvens, der koder for dette
MX9709596A (es) Adn catal ??tico.
ATE53608T1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
IT243461Y1 (it) Espositore di gioielli,particolarmente per vetrine.
BR1100781B1 (pt) receptor quimÉrico proteinÁceo ligado À membrana celular, dna que codifica o mesmo, bem como vetor compreendendo o referido dna.